Doxorubicin vs. Trabectedin Plus Doxorubicin in Non Operable and/or Metastatic STS
Status:
Terminated
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The proposed investigation intends to explore if the combination of trabectedin and
doxorubicin in the first line of treatment of advanced sarcomas obtains better results than
doxorubicin monotherapy